The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Healthcare Resource Utilization (HCRU)
Objective: To measure the impact of PSP disease severity on HCRU in a real-world setting. Background: PSP is a neurodegenerative disease. As it progresses, patients’…The Chinese Parkinson’s disease Registry scheme
Objective: This large prospective longitudinal cohort aims to identify nature history of a highly-presentative Chinese PD population and to discern clinical and genetic markers which…Motor-based assessment of prodromal Parkinson’s disease combining wearable sensors and machine learning
Objective: To provide the neurologist with a decision support system based on inertial sensors and learning algorithms for an objective early diagnosis of Parkinson’s disease…Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)
Objective: To assess the clinimetric properties of the Hebrew version of the UDysRS. Background: Dyskinesia is a common side effect of dopaminergic treatments for Parkinson's…Impaired intracortical inhibition predicts response to medication in Parkinson’s disease patients
Objective: To check whether measures of motor cortex excitability and plasticity are associated with clinical response to dopaminergic treatment in Parkinson’s disease (PD) patients. Background:…Characterising the role of alpha-synuclein in ferroptotic programmed cell death in the context of Parkinson’s Disease
Objective: Despite the involvement of alpha synuclein (α-syn) pathology in Parkinson's disease (PD) pathology, the consequences on the neuropathology and the type of programmed cell…Comparison of LFP-physiomarkers for DBS programming
Objective: To evaluate clinical usability of LFP(local field potentials)-physiomarkers and lead localisation for selection of suitable DBS electrode configurations. Background: Selection of optimal contacts in…Touching Nose: Alleviating Maneuvers (Sensory Tricks) in Orofacial Dystonia
Objective: Orofacial dystony is a type of focal dystonia that affects the facial and masticatory, cervical, laryngeal, eyelid, and pharyngeal muscles. Background: We present a…Botulinum toxin content and activity: Potential implications for duration of efficacy in patients with cervical dystonia
Objective: To quantify the amount of botulinum neurotoxin-A (BoNT-A) protein in each vial of commercial BoNT-A product and compare light chain activity of 150 kDa…Long-term treatment of cervical dystonia with abobotulinumtoxinA
Objective: To evaluate long-term efficacy and safety of the treatment of cervical dystonia (CD) with abobotulinumtoxinA in daily life routine in an outpatient clinic for…
- « Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 217
- Next Page »